Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5044334 | 0.87 | — | — | |
| SCHEMBL5424673 | 0.87 | PIK3CD (0.54) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL730495 | 0.85 | PIK3CD (0.48) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL19514132 | 0.85 | PIK3CD (0.52) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL5697292 | 0.85 | PIK3CD (0.52) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL989008 | 0.85 | PIK3CD (0.52) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL31632694 | 0.85 | PIK3CD (0.52) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL4397526 | 0.83 | PIK3CD (0.47) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL10481722 | 0.83 | PIK3CD (0.50) | PIK3CDKMT2AMEN1PKMMALT1 | |
| SCHEMBL261644 | 0.82 | PIK3CD (0.58) | PIK3CDKMT2AMEN1PKMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572608-B1 | HYDROFORMYLATION PROCESS FOR THE CONVERSION OF AN ETHYLENICALLY UNSATURATED COMPOUND TO AN ALCOHOL | SHELL INT RESEARCH (NL) | 2008-07-02 | — | — | EP | disclosed |
| US-7208606-B2 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | SHELL OIL COMPANY (US) | 2007-04-24 | — | — | US | disclosed |
| US-7186868-B2 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | SHELL OIL COMPANY (US) | 2007-03-06 | — | — | US | disclosed |
| US-20070032687-A1 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | SHELL USA, INC. | 2007-02-08 | — | — | US | disclosed |
| EP-1572608-A1 | HYDROFORMYLATION PROCESS FOR THE CONVERSION OF AN ETHYLENICALLY UNSATURATED COMPOUND TO AN ALCOHOL | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2005-09-14 | — | — | EP | disclosed |
| US-20040152928-A1 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | SHELL USA, INC. | 2004-08-05 | — | — | US | disclosed |
| WO-2004054946-A1 | HYDROFORMYLATION PROCESS FOR THE CONVERSION OF AN ETHYLENICALLY UNSATURATED COMPOUND TO AN ALCOHOL | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032687-A1 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | ADH1C, ADH1A, ADH5 | PIK3CD 2090/4885KMT2A 2268/4885MEN1 2394/4885 |
| US-20040152928-A1 | Hydroformylation process for the conversion of an ethylenically unsaturated compound to an alcohol | ADH1C, ADH1A, ADH5 | PIK3CD 2090/4885KMT2A 2268/4885MEN1 2394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.